Seminars in nuclear medicine
Current status of FAP therapy in solid tumors.
Sophie C Siegmund, Emil Novruzov, Eduards Mamlins, Yuriko Mori, Sven Otto, Martin Canis, Tadashi Watabe, Richard P Baum, Rudolf A Werner, Frederik L Giesel
Published: 202510.1053/j.semnuclmed.2025.11.022
Abstract
FAP-ligands as novel cancer radiopharmaceuticals in nuclear medicine have been recently translated successfully into the clinical space. Particularly small molecules (i.e. FAPI-46, FAPI-74) and peptides (i.e. FAP-2286, DOTAGA.SA.FAPi) seem to be some…
Preview only. Read the full abstract at the source